Sequence labelling tasks like Dialog Act and Emotion/Sentiment identification are a key component of spoken dialog systems. In this work, we propose a new approach to learn generic representations adapted to spoken dialog, which we evaluate on a new benchmark we call Sequence labellIng evaLuatIon benChmark fOr spoken laNguagE benchmark (\texttt{SILICONE}). \texttt{SILICONE} is model-agnostic and contains 10 different datasets of various sizes. We obtain our representations with a hierarchical encoder based on transformer architectures, for which we extend two well-known pre-training objectives. Pre-training is performed on OpenSubtitles: a large corpus of spoken dialog containing over $2.3$ billion of tokens. We demonstrate how hierarchical encoders achieve competitive results with consistently fewer parameters compared to state-of-the-art models and we show their importance for both pre-training and fine-tuning.
With the fast development of COVID-19 into a global pandemic, scientists around the globe are desperately searching for effective antiviral therapeutic agents. Bridging systems biology and drug discovery, we propose a deep learning framework for conditional de novo design of antiviral candidate drugs tailored against given protein targets. First, we train a multimodal ligand--protein binding affinity model on predicting affinities of antiviral compounds to target proteins and couple this model with pharmacological toxicity predictors. Exploiting this multi-objective as a reward function of a conditional molecular generator (consisting of two VAEs), we showcase a framework that navigates the chemical space toward regions with more antiviral molecules. Specifically, we explore a challenging setting of generating ligands against unseen protein targets by performing a leave-one-out-cross-validation on 41 SARS-CoV-2-related target proteins. Using deep RL, it is demonstrated that in 35 out of 41 cases, the generation is biased towards sampling more binding ligands, with an average increase of 83% comparing to an unbiased VAE. We present a case-study on a potential Envelope-protein inhibitor and perform a synthetic accessibility assessment of the best generated molecules is performed that resembles a viable roadmap towards a rapid in-vitro evaluation of potential SARS-CoV-2 inhibitors.
With the fast development of COVID-19 into a global pandemic, scientists around the globe are desperately searching for effective antiviral therapeutic agents. Bridging systems biology and drug discovery, we propose a deep learning framework for conditional de novo design of antiviral candidate drugs tailored against given protein targets. First, we train a multimodal ligand--protein binding affinity model on predicting affinities of antiviral compounds to target proteins and couple this model with pharmacological toxicity predictors. Exploiting this multi-objective as a reward function of a conditional molecular generator (consisting of two VAEs), we showcase a framework that navigates the chemical space toward regions with more antiviral molecules. Specifically, we explore a challenging setting of generating ligands against unseen protein targets by performing a leave-one-out-cross-validation on 41 SARS-CoV-2-related target proteins. Using deep RL, it is demonstrated that in 35 out of 41 cases, the generation is biased towards sampling more binding ligands, with an average increase of 83% comparing to an unbiased VAE. We present a case-study on a potential Envelope-protein inhibitor and perform a synthetic accessibility assessment of the best generated molecules is performed that resembles a viable roadmap towards a rapid in-vitro evaluation of potential SARS-CoV-2 inhibitors.
The task of predicting dialog acts (DA) based on conversational dialog is a key component in the development of conversational agents. Accurately predicting DAs requires a precise modeling of both the conversation and the global tag dependencies. We leverage seq2seq approaches widely adopted in Neural Machine Translation (NMT) to improve the modelling of tag sequentiality. Seq2seq models are known to learn complex global dependencies while currently proposed approaches using linear conditional random fields (CRF) only model local tag dependencies. In this work, we introduce a seq2seq model tailored for DA classification using: a hierarchical encoder, a novel guided attention mechanism and beam search applied to both training and inference. Compared to the state of the art our model does not require handcrafted features and is trained end-to-end. Furthermore, the proposed approach achieves an unmatched accuracy score of 85% on SwDA, and state-of-the-art accuracy score of 91.6% on MRDA.
The task of predicting dialog acts (DA) based on conversational dialog is a key component in the development of conversational agents. Accurately predicting DAs requires a precise modeling of both the conversation and the global tag dependencies. We leverage seq2seq approaches widely adopted in Neural Machine Translation (NMT) to improve the modelling of tag sequentiality. Seq2seq models are known to learn complex global dependencies while currently proposed approaches using linear conditional random fields (CRF) only model local tag dependencies. In this work, we introduce a seq2seq model tailored for DA classification using: a hierarchical encoder, a novel guided attention mechanism and beam search applied to both training and inference. Compared to the state of the art our model does not require handcrafted features and is trained end-to-end. Furthermore, the proposed approach achieves an unmatched accuracy score of 85% on SwDA, and state-of-the-art accuracy score of 91.6% on MRDA.
With the advent of deep generative models in computational chemistry, in silico anticancer drug design has undergone an unprecedented transformation. While state-of-the-art deep learning approaches have shown potential in generating compounds with desired chemical properties, they entirely overlook the genetic profile and properties of the target disease. In the case of cancer, this is problematic since it is a highly genetic disease in which the biomolecular profile of target cells determines the response to therapy. Here, we introduce the first deep generative model capable of generating anticancer compounds given a target biomolecular profile. Using a reinforcement learning framework, the transcriptomic profile of cancer cells is used as a context in which anticancer molecules are generated and optimized to obtain effective compounds for the given profile. Our molecule generator combines two pretrained variational autoencoders (VAEs) and a multimodal efficacy predictor - the first VAE generates transcriptomic profiles while the second conditional VAE generates novel molecular structures conditioned on the given transcriptomic profile. The efficacy predictor is used to optimize the generated molecules through a reward determined by the predicted IC50 drug sensitivity for the generated molecule and the target profile. We demonstrate how the molecule generation can be biased towards compounds with high inhibitory effect against individual cell lines or specific cancer sites. We verify our approach by investigating candidate drugs generated against specific cancer types and investigate their structural similarity to existing compounds with known efficacy against these cancer types. We envision our approach to transform in silico anticancer drug design by increasing success rates in lead compound discovery via leveraging the biomolecular characteristics of the disease.
Information extraction and data mining in biochemical literature is a daunting task that demands resource-intensive computation and appropriate means to scale knowledge ingestion. Being able to leverage this immense source of technical information helps to drastically reduce costs and time to solution in multiple application fields from food safety to pharmaceutics. We present a scalable document ingestion system that integrates data from databases and publications (in PDF format) in a biochemistry knowledge graph (BCKG). The BCKG is a comprehensive source of knowledge that can be queried to retrieve known biochemical facts and to generate novel insights. After describing the knowledge ingestion framework, we showcase an application of our system in the field of carbohydrate enzymes. The BCKG represents a way to scale knowledge ingestion and automatically exploit prior knowledge to accelerate discovery in biochemical sciences.